Clinical Study

Ucci-Hn-19-02- Determining Hbd-3 As A Valid Biomarker In Head And Neck Cancer.

Posted Date: Oct 15, 2019

  • Investigator: Chad Zender
  • Specialties: Cancer, Head and Neck Cancer, Oncology
  • Type of Study: Observational/Survey

The goal of this study is to replicate the beta defensin index's ability to distinguish oral squamous cell carcinoma from non-cancerous lesions

Criteria:

To Be Eligible: 18 Years Or Older, Diagnosis Of Head And Neck Cancer, Any Condition Pi Finds To Be Confounding With Their Ability To Properly Participate In The Study

Keywords:

Head And Neck Cancer, Hnc, Oncology

For More Information:

Ucci Cancer Instituteq
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.